- This event has passed.
Cases and Considerations in PAH: From Diagnosis to Effective Treatment
October 17, 2021 from 5:15 pm - 6:15 pm CDT
Supported By: Actelion, a Janssen pharmaceutical company of Johnson & Johnson, Bayer, Merck, and United Therapeutics
In this interactive CME live symposium, experts in the field of pulmonary arterial hypertension (PAH) will engage in discussion and dissect a patient case that addresses best practices for recognizing, diagnosing, and treating PAH in clinical practice to improve patient outcomes. By participating in this activity, learners will gain insight to evidence-based approaches to appropriate risk assessment in PAH, guideline-directed strategies to set and treat to specific PAH treatment goals, best practices to tailor and adjust PAH therapy to meet treatment goals and achieve low-risk status, as well as approaches to effectively monitor PAH patients throughout the course of the disease.
Disclaimer: This symposium is not supported, endorsed, or accredited by the American College of Chest Physicians
Vallerie V. McLaughlin, MD, FACC, FAHA, FCCP
Kim A. Eagle, MD, Endowed Professor of Cardiovascular Medicine
Pulmonary Hypertension Program
University of Michigan
Ann Arbor, Michigan
Murali Chakinala, MD, FCCP
Professor of Medicine,
Washington University &
Barnes-Jewish Hospital Pulmonary Hypertension Care Center
St Louis, Missouri